CZC-54252
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Novel, potent and selective inhibitor of the leucine-rich repeat kinase-2 (LRRK2), IC50 = 1.28 nM. Also inhibits G2019S mutant LRRK2, IC50 = 1.85 nM1. Attenuates the neuronal damage elicited by the action of LRRK2 G2019S mutant in primary human neurons (EC50 = 1 nM) 1. The G2019S mutant is a common mutation found in familial Parkinson’s disease patients2. Cell permeable.
Unconjugated
Off-white solid
-20°C
Beschrijving
CZC-54252 Beschikbaar in 5 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Drug Stability Chamber
500-DSC102
1 Unit
Modular Incubator Chamber
MIC-101
1 Unit
CYP707A2 Antibody
GTR17947107
2 mg
SsDNA Assay Kit
12645ES60
100 Tests
Eco Alu MTP (HxD) 6x7=42 plates 35mm, 223x630x135mm
TE15336
1 Piece
Arachis hypogaea Lectin (PNA) - Biotinylated
21510020-1
5mg
Cellubrevin Antibody
MBS9436639-01
0.05 mL
Oxidative Stress Combo Assay Tissue Kit
EA-7008
1 Each
Recent gezochte producten
BDBV Nucleoprotein Recombinant Protein (N-His)
VK059012-01
50 µg
KBFP720 700L Stability Chamber
CHA3020
1 Each
KBFLQC240 247L Stability Chamber
CHA3022
1 Each
KBF1020 1020L Stability Chamber
CHA3024
1 Each
Stability Chamber KBFP240 247L
CHA3030
1 Each
Drug Stability Chamber
150-DSC100
1 Unit
Drug Stability Chamber
150-DSC200
1 Unit
Drug Stability Chamber
250-DSC101
1 Unit